Sarepta Therapeutics, Inc.
USD17.41
+0.39 (+2.30%)
CEO
Douglas S. Ingram
IPO Date
1997-06-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$17.50
Prev. Close
$17.02
Day Low
$16.91
Day High
$17.55
52W Low
$10.42
52W High
$25.32
Market Cap
$1.84B
Volume
0.19M
| 49.1 |
| 31 Dec 2023 | FY | 87.9% | -43.1% | -62.4% | -16.4% | 1.63 | 3.95 | -16.6 |
| 31 Dec 2022 | FY | 85.0% | -75.4% | -182.7% | -22.5% | 4.20 | 4.13 | -16.1 |
| 31 Dec 2021 | FY | 86.2% | -59.7% | -45.1% | -13.3% | 1.24 | 5.75 | -17.5 |
| 31 Dec 2020 | FY | 88.3% | -102.6% | -72.7% | -18.6% | 1.44 | 5.97 | -24.0 |
| 31 Dec 2019 | FY | 85.1% | -187.8% | -87.4% | -39.2% | 0.90 | 5.55 | -13.3 |
| 31 Dec 2018 | FY | 88.6% | -120.2% | -35.1% | -22.0% | 0.41 | 8.21 | -20.0 |
| 31 Dec 2017 | FY | 95.2% | -32.8% | -6.4% | -3.9% | 0.55 | 13.91 | -64.6 |
| 31 Dec 2016 | FY | 97.6% | -4930.2% | -79.4% | -63.0% | 0.05 | 4.95 | -5.0 |
| -2.0 |
| 30 Sept 2025 | Q3 | 62.2% | -45.1% | -13.6% | -5.2% | 0.95 | 2.95 | -2.7 |
| 30 Jun 2025 | Q2 | 75.0% | 32.2% | 14.5% | 5.4% | 1.00 | 2.89 | 2.1 |
| 31 Mar 2025 | Q1 | 81.5% | -60.1% | -39.2% | -12.9% | 1.18 | 4.02 | -3.5 |
| 31 Dec 2024 | Q4 | 79.9% | 24.2% | 10.4% | 4.0% | 0.88 | 4.20 | 18.4 |
| 30 Sept 2024 | Q3 | 80.4% | 7.2% | 2.8% | 0.9% | 1.14 | 3.84 | 88.6 |
| 30 Jun 2024 | Q2 | 87.7% | 1.8% | 0.6% | 0.2% | 1.27 | 3.90 | 574.0 |
| 31 Mar 2024 | Q1 | 87.8% | 8.7% | 3.8% | 1.1% | 1.44 | 4.05 | 83.5 |
| 31 Dec 2023 | Q4 | 88.9% | 11.5% | 5.3% | 1.4% | 1.63 | 3.95 | 49.4 |